SUZHOU KINTOR PHARMACEUTICALS
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.
SUZHOU KINTOR PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.kintor.com.cn
Total Employee:
11+
Status:
Active
Contact:
+86-512-62956307
Email Addresses:
[email protected]
Total Funding:
99 M USD
Technology used in webpage:
Domain Not Resolving Euro Amazon CloudFront AWS Cloudfront Ashburn VA Edge
Similar Organizations
Curon Biopharma
Curon Biopharma is a Healthcare company.
eSense-Lab
eSense-Lab is an Israel-based pharmaceutical technology company
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Healsun Biopharm
Healsun Biopharm is a pharmaceutical company.
K2Biomedical
K2Biomedical is a pharmaceutical research company.
Nidhi Infotech
Nidhi infotech is a leading IT, analytical, clinical research company.
Northwest Clinical Trials
Northwest Clinical Trials is a medical research clinic.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
CCB International
CCB International investment in Series D - Suzhou Kintor Pharmaceuticals
FTZ Fund
FTZ Fund investment in Series D - Suzhou Kintor Pharmaceuticals
Highlight Capital
Highlight Capital investment in Series D - Suzhou Kintor Pharmaceuticals
Huajin Capital
Huajin Capital investment in Series D - Suzhou Kintor Pharmaceuticals
Oriza Holdings
Oriza Holdings investment in Series C - Suzhou Kintor Pharmaceuticals
Green Pine Capital Partners
Green Pine Capital Partners investment in Series C - Suzhou Kintor Pharmaceuticals
Broad Resources
Broad Resources investment in Series C - Suzhou Kintor Pharmaceuticals
China Orient Asset Management (International) Holding
China Orient Asset Management (International) Holding investment in Series C - Suzhou Kintor Pharmaceuticals
CCB International
CCB International investment in Series C - Suzhou Kintor Pharmaceuticals
Highlight Capital
Highlight Capital investment in Series C - Suzhou Kintor Pharmaceuticals
Official Site Inspections
http://www.kintor.com.cn Semrush global rank: 1.84 M Semrush visits lastest month: 12.19 K
- Host name: 120.133.2.80
- IP address: 120.133.2.80
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
